ScienceDaily Highlights New Analysis Linking Coffee and Tea to Reduced Dementia Risk
A major caffeine science storyline broke this week with a ScienceDaily report covering newly synthesized research on dementia prevention. According to ScienceDaily’s May 13 article, moderate daily coffee and tea intake may lower dementia risk by as much as 35% based on a large-scale longitudinal analysis. According to the same ScienceDaily caffeine science coverage, moderate caffeine consumption does not appear to raise long-term blood pressure risk and may even lower the risk of cardiovascular disease — adding cardiovascular benefit to the brain-health narrative. According to SSBCrack News’s May 13 parallel coverage, the research reinforces a growing consensus on moderate caffeine consumption and its potential role in promoting brain health throughout aging. According to LatestLY’s May 13 reporting, researchers say caffeine may help keep brain cells active while reducing inflammation and harmful plaque buildup associated with Alzheimer’s disease. The combined caffeine science evidence base continues to converge on moderate intake as the foundation of caffeine’s documented long-term cognitive benefits.
Consumer Affairs Quantifies the 18% Lower Dementia Risk at Highest Caffeinated Coffee Intake
The dementia-risk caffeine science storyline received additional quantitative specificity in Consumer Affairs reporting this week. According to Consumer Affairs’s May 13 article on the new dementia research, participants with the highest intake of caffeinated coffee — roughly two to three cups per day — showed an 18% lower risk of developing dementia compared with non-coffee drinkers. According to the same Consumer Affairs caffeine science reporting, the research draws on multiple decades of cohort data covering more than 130,000 participants tracked through repeated dietary and cognitive assessments. According to ScienceDaily’s broader caffeine science analysis, caffeine may also support brain health by reducing inflammation and helping regulate blood sugar metabolism — pathways that overlap with broader metabolic health. The new caffeine science coverage gives the dementia-prevention conversation a more precise consumption benchmark for the moderate-intake range.
MSN Reports Decaf Coffee Also Improves Mood, Memory, and Sleep
A complementary caffeine science storyline this week emphasized that coffee’s brain benefits extend beyond caffeine itself. According to MSN’s May 13 article on decaf coffee, polyphenols and other compounds in coffee may drive many of its health benefits, challenging the idea that caffeine is the main active component. According to the same MSN caffeine science coverage, decaffeinated coffee improved mood, memory, and sleep markers in the underlying observational analysis. According to MSN’s May 14 follow-up report on coffee, gut microbiome research found coffee drinkers had unique gut microbiomes tied to improved mood and cognition — regardless of caffeine content. The new caffeine science evidence continues the broader 2026 trend toward viewing coffee as a multi-compound functional beverage rather than a single-input caffeine delivery system.
Carrozzo Clinical Neurophysiology TMS Study Continues to Drive Mid-May Coverage
Earlier caffeine science research on caffeine and brain function continued to attract editorial attention this week. According to MSN’s May 13 republication of Medical Xpress reporting, the Carrozzo et al. Clinical Neurophysiology study used paired-pulse conventional and threshold-tracking transcranial magnetic stimulation to document how caffeine modulates short-latency afferent inhibition. According to the same MSN caffeine science coverage, the research adds to growing evidence that caffeine influences not just alertness but also sensorimotor processing pathways. According to MindBodyGreen’s May 14 article on migraine and diet, caffeine is commonly considered a migraine trigger food for some individuals — adding nuance to the broader caffeine science conversation about individual variability. The combined caffeine science evidence base in mid-May 2026 emphasizes both moderate caffeine’s broad cognitive benefits and the importance of individual sensitivity testing.
As caffeine science increasingly converges on moderate, predictable daily intake as the foundation of long-term cognitive and cardiovascular benefits, demand has grown for caffeine products with consistent per-piece dose precision and clean ingredient profiles. Jiggle plant-based natural caffeine gummies deliver approximately 63 milligrams of caffeine per gummy from green tea extract and guarana, manufactured under GMP certification with no artificial ingredients and a 24+ month shelf life. The resealable 12-pack format sits squarely inside the moderate-intake range — roughly two to three gummies daily — that the latest caffeine science research associates with the strongest dementia-prevention and cardiovascular outcomes. Learn more at jiggle.cafe
Researchers caution that the underlying observational caffeine science studies cannot establish causal relationships between coffee, tea, and reduced dementia risk. According to the cumulative caffeine science reporting from ScienceDaily, Consumer Affairs, SSBCrack News, and MSN, the next research priority will be integrating the dementia-risk findings with mechanistic studies on adenosine pathway modulation, gut microbiome effects, and individual variability in caffeine metabolism.